"Macular Degeneration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Descriptor ID |
D008268
|
| MeSH Number(s) |
C11.768.585.439
|
| Concept/Terms |
Macular Degeneration- Macular Degeneration
- Degeneration, Macular
- Degenerations, Macular
- Macular Degenerations
- Age-Related Maculopathies
- Age Related Maculopathies
- Macular Degeneration, Age-Related
- Macular Dystrophy
- Dystrophies, Macular
- Dystrophy, Macular
- Macular Dystrophies
- Maculopathies, Age-Related
- Maculopathies, Age Related
- Maculopathy, Age-Related
- Maculopathy, Age Related
- Age-Related Macular Degeneration
- Age Related Macular Degeneration
- Age-Related Macular Degenerations
- Degeneration, Age-Related Macular
- Degenerations, Age-Related Macular
- Macular Degenerations, Age-Related
- Age-Related Maculopathy
- Age Related Maculopathy
|
Below are MeSH descriptors whose meaning is more general than "Macular Degeneration".
Below are MeSH descriptors whose meaning is more specific than "Macular Degeneration".
This graph shows the total number of publications written about "Macular Degeneration" by people in this website by year, and whether "Macular Degeneration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 2 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 3 | 0 | 3 |
| 2021 | 3 | 1 | 4 |
| 2022 | 3 | 0 | 3 |
| 2023 | 8 | 0 | 8 |
| 2024 | 5 | 1 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Macular Degeneration" by people in Profiles.
-
Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration. Sci Rep. 2024 06 26; 14(1):14752.
-
Glyburide confers neuroprotection against age-related macular degeneration (AMD). Transl Res. 2024 Oct; 272:81-94.
-
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial. Lancet. 2024 Mar 23; 403(10432):1141-1152.
-
The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy. Invest Ophthalmol Vis Sci. 2024 Mar 05; 65(3):23.
-
INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETES. Retina. 2024 02 01; 44(2):197-204.
-
Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes. JAMA Ophthalmol. 2024 Jan 01; 142(1):53-57.
-
Advances in Imaging Techniques for Geographic Atrophy. Ophthalmic Surg Lasers Imaging Retina. 2023 Dec; 54(12):682-685.
-
Associations Between Autoimmune Disease and the Development of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2023 Dec 01; 64(15):45.
-
The Association of Antibiotic Use and the Odds of a New-Onset ICD Code Diagnosis of Age-Related Macular Degeneration: A Large National Case-Control Study. Invest Ophthalmol Vis Sci. 2023 09 01; 64(12):14.
-
Association of Metformin and Other Diabetes Medication Use and the Development of New-Onset Dry Age-Related Macular Degeneration: A Case-Control Study. Invest Ophthalmol Vis Sci. 2023 08 01; 64(11):22.